We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.


The Manchester Biomedical Research Centre launches new chapter

At a conference with over 200 delegates the Manchester Biomedical Research Centre set out its new strategy and aims for the future.

Taking a prime spot at the Central Manchester University Hospitals NHS Foundation Trust's annual Research and Innovation Conference on 3rd December, the Manchester Biomedical Research Centre launch included talks from Professor Alistair Burns, Clinical Director of MAHSC, Mr Mike Deegan, Chief Executive of CMFT, Professor Colin Sibley, Director of the Manchester BRC and Head of Research and Innovation at CMFT and Professor Graeme Black, Director of the Institute of Human Development and Deputy Director of the Manchester BRC.

(L-R) Mike Deegan, Professor Alistair Burns, Professor Graeme Black, Professor Colin Sibley

The presentations set out the BRC's commitment to 'improving healthcare through science' in partnership with The University of Manchester and CMFT.  With continued investment from CMFT, as well as support from industrial partners, research charities and success in competitive funding, the BRC is focused on nurturing and facilitating experimental medicine research that will have an impact on healthcare with an emphasis on issues of particular importance to the people of the North West. The Manchester BRC Steering Group brings together internationally respected researchers with a remit to ensure the BRC's research is of the highest quality and both topical and relevant to health issues.

Professor Colin Sibley said during the launch: "Entering the new chapter of the Manchester BRC we are committed to improving healthcare through science for the local, national and global population. Being part of MAHSC we know that collaboration and partnerships is key in translating research from university based laboratories to clinical settings within Manchester's hospitals.

We believe we can make a real difference to the lives of the patients who pass through our hospitals each day, with outcomes that will be relevant to many similar groups of people nationally and internationally."